# Recurrent Stroke Prevention Clinical Outcome Study

> **NCT01198496** · PHASE4 · UNKNOWN · sponsor: **Biomedis International Ltd.** · enrollment: 5000 (estimated)

## Conditions studied

- Hypertension
- Stroke
- Blood Pressure

## Interventions

- **DRUG:** Losartan, Losartan and HCTZ, Amlodipine , Spironolactone

## Key facts

- **NCT ID:** NCT01198496
- **Lead sponsor:** Biomedis International Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2017-12
- **Final completion:** 2019-12
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2012-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198496, "Recurrent Stroke Prevention Clinical Outcome Study". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01198496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*